ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

NIH Panel Calls For More Attention to Cancer Pain

July 26, 2002

Analysis Finds Exercise Lowers Colon Cancer Risk

February 27, 2009

Scientists Lobby For Funding Increase. DuBois To Leave Vanderbilt For M.D. Anderson.

January 12, 2007

Funding Mechanisms: How They Are Used

August 12, 1983